Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. (Q51867713)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 June 2009

Language	Label	Description	Also known as
English	Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.	scientific article published on 10 June 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

0 references

0 references

Alzheimer's disease

1 reference

based on heuristic

inferred from title

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Yvonne Freund-Levi

6

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

Lars-Olof Wahlund

object named as

Lars-Olof Wahlund

5

0 references

Philip Scheltens

4

object named as

Philip Scheltens

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

10

object named as

Harald Hampel

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

Hilkka Soininen

13

object named as

Hilkka Soininen

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

17

object named as

Kaj Blennow

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

Lennart Minthon

8

object named as

Lennart Minthon

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

Magda N. Tsolaki

7

object named as

Magda Tsolaki

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

Frans RJ Verhey

2

object named as

Frans Verhey

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

15

object named as

Marcel M Verbeek

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

Pieter Jelle Visser

1

object named as

Pieter Jelle Visser

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

9

object named as

Asa K Wallin

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

Marcel G.M. Olde Rikkert

14

object named as

Marcel Olde Rikkert

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

16

object named as

Luiza Spiru

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

Tuula Pirttilä

12

object named as

Tuula Pirttila

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

3

object named as

Dirk L Knol

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

author name string

Katharina Bürger

11

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

publication date

10 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

8

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

7

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

619-627

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Clinical Dementia Rating (CDR): current version and scoring rules

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cornell Scale for Depression in Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity of the Trail Making Test as an Indicator of Organic Brain Damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Visual association test to detect early dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-word recall in normal aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of interference in serial verbal reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential hypometabolism patterns according to mild cognitive impairment subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of atrophy differ among specific subtypes of mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970139-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(09)70139-5

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19523877

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51867713&oldid=1857630362"